Emyria Limited (ASX: EMD)
Health Care · Pharmaceuticals · AU
AU$0.04
-6.67% today · -36.4% 1Y
Emyria Limited (ASX: EMD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $23.64M and employs 6 people.
Over the last twelve months the share price has lost 36.4%, trading between 0.04 and 0.08.
Tweenvest scores Emyria Limited across four factors: quality 36/100, value 58/100, growth 100/100. Its strongest factor is growth.
EMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.64M
- Revenue (TTM)
- $2.80M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- AU$0.08
- 52-week low
- AU$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 806.56M
- Employees
- 6
- Next earnings
- —
About Emyria Limited
Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.
- ISIN
- AU0000073645
- Founded
- 2018
- Listed since
- Feb 11, 2020
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gennex Laboratories LimitedBSE: 531739 | $24.12M | Rs9.61 | -1.94% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| TherapeuticsMD, Inc.NasdaqGS: TXMD | $23.84M | $2.02 | -1.94% |
| Quantum BioPharma Ltd.NasdaqCM: QNTM | $23.78M | $2.80 | -4.76% |
| Kontafarma China Holdings LimitedSEHK: 1312 | $23.50M | HK$0.03 | +3.13% |
| Tdspharm Co., Ltd.KOSDAQ: A464280 | $22.99M | ₩5,590.00 | +3.71% |
| BCWORLD PHARM. Co., Ltd.KOSDAQ: A200780 | $22.96M | ₩3,020.00 | -0.98% |
| Sanjivani Paranteral LimitedBSE: 531569 | $22.88M | Rs180.25 | +9.18% |
Figures last refreshed Oct 11, 2026.